ADAM17 and melanoma: To evaluate the anti-cancer effects in melanoma cells, Huang et al. reported that RA inhibits the invasion, proliferation, and migration of human melanoma A375 cells, promotes apoptosis, and increases theCisplatin sensitivity of melanoma cells by inhibiting the ADAM17/EGFR/AKT/GSK3β pathway [60].